Literature DB >> 7078029

[The significance of LP-X cholesterol in the differential diagnosis of cholestasis (author's transl)].

H Wieland, H Meissner-Heins, C Heins, D Seidel.   

Abstract

The aim of this study was to investigate whether quantification of Lipoprotein X (LP-X) through its cholesterol moiety is advantageous in the differential diagnosis of obstructive jaundice. In the case of mechanic cholestasis, LP-X cholesterol never exceeds 22% of the total serum cholesterol. Lipoprotein-X cholesterol exceeded 70 mg/dl in the plasma of 85% of all cases of acute hepatitis. The combination of lipoprotein with the activities of alkaline phosphatase and GPT allows the recognition of almost 80% of cases acute hepatitis and thereby excludes all other causes of obstructive jaundice. In addition, 84% of all patients investigated can be correctly classified using a combination of LP-X with classical parameters for cholestasis. The concentration of LP-X cholesterol alone apparently is as powerful as the usually used clinical chemical parameters. A combination of lipoprotein and the classical parameters allows a better differentiation of cholestatic liver disease with regard to the underlying cause as it is possible with each group of parameters alone.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7078029     DOI: 10.1007/bf01721624

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  9 in total

1.  [A new and simplified method for the detection of LP-X, a cholestasis specific lipoprotein].

Authors:  H Wieland; D Seidel
Journal:  Dtsch Med Wochenschr       Date:  1973-08       Impact factor: 0.628

2.  Significance of the LP-X test in differential diagnosis of jaundice.

Authors:  D Seidel; H Gretz; C Ruppert
Journal:  Clin Chem       Date:  1973-01       Impact factor: 8.327

3.  Plasma lipoproteins in liver disease. I. Immunologically distinct low-density lipoproteins in patients with biliary obstruction.

Authors:  S Switzer
Journal:  J Clin Invest       Date:  1967-11       Impact factor: 14.808

4.  Improved techniques for assessment of plasma lipoprotein patterns. I. Precipitation in gels after electrophoresis with polyanionic compounds.

Authors:  D Seidel; H Wieland; C Ruppert
Journal:  Clin Chem       Date:  1973-07       Impact factor: 8.327

5.  [Precipitation of alpha lipoproteins in serum by sodium phosphotungstate in the presence of magnesium chloride].

Authors:  M Burstein; R Morfin
Journal:  Life Sci       Date:  1969-04-15       Impact factor: 5.037

6.  Enzymatic determination of lipoprotein-X, a specific serum cholestasis marker.

Authors:  E Talafant; J Továrek
Journal:  J Clin Chem Clin Biochem       Date:  1981-03

7.  Formation of lipoprotein-X. Its relationship to bile compounds.

Authors:  E Manzato; R Fellin; G Baggio; S Walch; W Neubeck; D Seidel
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

8.  Plasma lipoproteins in patients with familial plasma lecithin: cholesterol acyltransferase (LCAT) deficiency--studies on the apolipoprotein composition of isolated fractions with identification of LP-X.

Authors:  D Seidel; E Gjone; J P Blomhoff; H P Geisen
Journal:  Horm Metab Res       Date:  1974       Impact factor: 2.936

9.  A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects.

Authors:  D Seidel; P Alaupovic; R H Furman
Journal:  J Clin Invest       Date:  1969-07       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.